Compare MCO & MDT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | MCO | MDT |
|---|---|---|
| Founded | 1900 | 1949 |
| Country | United States | Ireland |
| Employees | N/A | N/A |
| Industry | Finance: Consumer Services | Biotechnology: Electromedical & Electrotherapeutic Apparatus |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 89.2B | 107.0B |
| IPO Year | 1998 | 2014 |
| Metric | MCO | MDT |
|---|---|---|
| Price | $463.92 | $88.57 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 24 | 29 |
| Target Price | ★ $560.38 | $104.44 |
| AVG Volume (30 Days) | 541.7K | ★ 22.1M |
| Earning Date | 10-21-2026 | 11-17-2026 |
| Dividend Yield | 0.90% | ★ 3.28% |
| EPS Growth | ★ 21.40 | 3.32 |
| EPS | ★ 8.75 | 1.14 |
| Revenue | $4,204,100,000.00 | ★ $36,364,000,000.00 |
| Revenue This Year | $7.33 | $7.18 |
| Revenue Next Year | $7.25 | $3.65 |
| P/E Ratio | ★ $52.42 | $76.97 |
| Revenue Growth | N/A | ★ 8.43 |
| 52 Week Low | $402.28 | $73.31 |
| 52 Week High | $546.88 | $106.33 |
| Indicator | MCO | MDT |
|---|---|---|
| Relative Strength Index (RSI) | 48.60 | 48.02 |
| Support Level | $439.15 | $85.31 |
| Resistance Level | $469.05 | $89.00 |
| Average True Range (ATR) | 8.57 | 2.14 |
| MACD | 0.88 | -0.17 |
| Stochastic Oscillator | 61.27 | 42.55 |
Moody's, along with S&P Ratings, is a leading provider of credit ratings on fixed-income securities. The ratings segment, Moody's Investors Service, includes corporates, structured finance, financial institutions, and public finance ratings. MIS represents a majority of the firm's profit and often (depending on bond issuance levels) a majority of the firm's revenue. The other segment, Moody's Analytics, consists of decision solutions, research and insights, and data and information.
One of the largest medical-device companies, Medtronic develops and manufactures therapeutic medical devices for chronic diseases. Its portfolio includes pacemakers, defibrillators, transcatheter heart valves, stents, spinal fixation devices, neurovascular products, advanced energy, ablation laser therapy, and surgical tools. The company primarily markets its products to healthcare institutions and physicians in the United States, Western Europe, and Japan. Foreign sales account for roughly 50% of the company's total sales.